Daisuke Kotani, GI Medical Oncologist, Chief Physician at the Department of Gastrointestinal Oncology at the National Cancer Center Hospital East, Japan, shared a post on X:
“Our latest RWD study is now available online in The Oncologist!
A prospective observational study of EC vs. EC + Binimetinib for BRAF-mutated mCRC.”
Title: Real-world outcomes of encorafenib, cetuximab ± binimetinib for BRAF‑mutated metastatic colorectal cancer: The BEETS (JACCRO CC‑18) study
Authors: Daisuke Kotani, Eisuke Inoue, Tadamichi Denda, Chiaki Inagaki, Tomomi Kashiwada, Yoshiaki Mihara, Akinori Sugaya, Yusuke Suwa, Takashi Ohta, Hidekazu Kuramochi, Kotoe Oshima, Satoshi Yuki, Manabu Shiozawa, Akihito Tsuji, Kei Muro, Wataru Ichikawa, Masashi Fujii, Yu Sunakawa
Read the Full Article.
Other articles about Daisuke Kotani on OncoDaily.